An assessment of the antihyperlipidemic ingredients of Qi Ge Decoction based on metabolomics combined with serum pharmacochemistry
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.5922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Hui Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Metabolomics, Hypolipidemic Agents, Hyperlipidemias. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Guangzhou University of Chinese Medicine, Guangdong Natural Science Foundation Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
This study aims to explore the pharmacological substance basis of Qi Ge Decoction (QG) in antihyperlipidemia through a combination of metabolomics and serum pharmacochemistry. We used ultra‐performance liquid chromatography quadrupole‐time‐of‐flight/MS (UPLC Q‐TOF/MS) to analyze and identify the chemical constituents of QG in vitro and in blood chemical components. The metabolomics technology was used to analyze serum biomarkers of QG in preventing and treating hyperlipidemia. We constructed a mathematical model of the relationship between constituents absorbed into the blood and endogenous biomarkers and explored the potential therapeutic application of QG for the prevention and treatment of hyperlipidemia. Compared with the model group, the levels of total cholesterol and triglyceride in the QG group were significantly decreased ( P < 0.01). A total of 12 chemical components absorbed into the blood were identified, and 48 biomarkers of the hyperlipidemia model were obtained from serum metabolomic analysis, of which 15 metabolites were backregulated after QG intervention. Puerarin, hesperetin, puerarin xyloside, calycosin, and monohydroxy‐tetramethoxyflavone had a high correlation with the biomarkers regulated by QG. This study elucidated the material basis of QG in the intervention of hyperlipidemia, thereby facilitating future research aimed at further revealing the pharmacodynamic material basis of QG's antihyperlipidemic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
- Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
ORCID-Profile: Hui Tang, Xue Hong Ke
Förderung
- Guangzhou University of Chinese Medicine
- Guangdong Natural Science Foundation Project
- National Natural Science Foundation of China
Zitieren
APA
Tang, H., Guo, K. X., Huang, K. E., Li, Y. F., Chen, W., Wei, H. Y., Yu, X. Q., & Ke, X. H. (2024). An assessment of the antihyperlipidemic ingredients of Qi Ge Decoction based on metabolomics combined with serum pharmacochemistry. Biomedical Chromatography. https://doi.org/10.1002/bmc.5922
Vancouver
Tang H, Guo KX, Huang KE, Li YF, Chen W, Wei HY, et al. An assessment of the antihyperlipidemic ingredients of Qi Ge Decoction based on metabolomics combined with serum pharmacochemistry. Biomedical Chromatography. 2024. doi:10.1002/bmc.5922
BibTeX
@article{Tang2024,
author = {Tang, Hui and Guo, Kai Xin and Huang, Ke Er and Li, Yan Fang and Chen, Wei and Wei, Hao Yang and Yu, Xiao Qing and Ke, Xue Hong},
title = {An assessment of the antihyperlipidemic ingredients of Qi Ge Decoction based on metabolomics combined with serum pharmacochemistry},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.5922}
}
EUVIMED